Brokerages Set CRISPR Therapeutics AG (NASDAQ:CRSP) Target Price at $74.50
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty-two ...
Why CRISPR Therapeutics (CRSP) Soared on Friday?
We recently published a list of Shares of 10 Firms Soar on Friday. In this article, we are going to take a look at where ...
CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99
CRISPR's upcoming trial data and increasing demand for Casgevy drive Evercore's bullish outlook and a higher price target ...
Nasdaq7d
April 4th Options Now Available For CRISPR Therapeutics (CRSP)
Investors in CRISPR Therapeutics AG (Symbol: CRSP) saw new options begin trading today, for the April 4th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...